TheEdgeResearch
Home / Stocks / ABV.AX

Advanced Braking Technology Limited (ABV.AX)

ASX Consumer Cyclical Auto - Parts
$0.13 ▲ +6.12%
Market Cap
$51.7M
Sector
Consumer Cyclical
Industry
Auto - Parts
Beta
1.00
52-Wk Range
0.094-0.16
CEO
Andrew Booth
Country
AU
Currency
AUD

Advanced Braking Technology Limited operates in the Auto - Parts industry of the Consumer Cyclical sector, headquartered in Wangara, WA, AU. The stock last traded at $0.13, up 6.12% on the session, giving a market capitalisation of $51.7M. Its beta of 1.00 implies it has historically moved less than the broad market.

Company profile
Exchange
Australian Securities Exchange
Employees
27
IPO date
2021-11-22
Headquarters
Wangara, WA, AU
About Advanced Braking Technology Limited

Advanced Braking Technology Limited engages in the research, design, development, manufacture, distribution, and sale of braking solutions worldwide. The company offers brakes for light, medium, and heavy vehicles; and ABT failsafe brakes, ABT failsafe emergency driveline brakes, and associated braking systems. It also provides BrakeSAFE Wheel End SIBS Brakes, a sealed wet brakes with spring applied hydraulic release mechanism and optional interlocks that eliminates the risk of unintended vehicle movement; BrakeSAFE Driveline SIBS Brakes which act as a supplementary system for critical situations that provides rapid intervention, and preventing unintended vehicle movements during service break failure; and BRAKEiQ, an auto braking system designed to integrate with collision avoidance systems. The company serves mining, defense, civil construction, and waste management industries. Advanced Braking Technology Limited was founded in 1992 and is headquartered in Wangara, Australia.

Comparable companies

Advanced Braking Technology Limited is most often compared with the following Consumer Cyclical names:

CCX.AXMFD.AXMPA.AXNTD.AXRPM.AXSHM.AXSIO.AXSIX.AXVMT.AXXRG.AX
More research on ABV.AX
ABV.AX technical analysis ABV.AX TheEdge Score Compare against peers
Open full interactive analysis & DCF →